✦ LIBER ✦

PCN116 Cost-Effectiveness of Denosumab Versus Zoledronic Acid (ZA) for the Prevention of Skeletal-related Events (SRE) in Patients with Bone Metastases from Solid Tumors in the Netherlands

✍ Scribed by Lothgren, M.; Bracco, A.; Lucius, B.; Northridge, K.; Halperin, M.; Macarios, D.; Chung, K.; Danese, M.D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN132 MODELING THE LIFETIME EFFECTIVENE

✍ M.D. Danese; A. Bracco; D. Macarios; K. Chung; A. Barlev; M. Halperin; M. Lothgr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Cost-effectiveness of denosumab vs zoled

✍ Stopeck, Alison; Rader, Michael; Henry, David; Danese, Mark; Halperin, Marc; Con 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 264 KB

PCN66 Cost-Effectiveness of Denosumab Ve

✍ M.F. Botteman; J.A. Carter; P. Fishman; D. Chandiwana; M. Bains; S.J. Snedecor 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Economic Evaluation Of Denosumab Versus

✍ Arocho, R.; Rivera Hurtado, R.; Carlos, F. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Denosumab for the Prevention of Skeletal

✍ Maryam Iranikhah; Teresa W. Wilborn; Terri M. Wensel; Jodi B. Ferrell 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN27 COMPARATIVE BUDGET IMPACT OF FORMU

✍ M.J. Bell; J.D. Miller; M. Namjoshi; M.W. Russell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB